Magnetic resonance imaging: Implication in acute ischemic stroke management

Current Atherosclerosis Reports

Volumn 7, Issue 4, 2005, Pages 305-312

  Sitburana, Oraporn ^a   Koroshetz, Walter J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOTEPLASE; PLACEBO;

BRAIN BLOOD VESSEL; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN TISSUE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT CARE; PERFUSION WEIGHTED IMAGING; REVIEW;

EID: 27744459993     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-005-0023-3     Document Type: Review

References (48)

1. Lin W, Lee JM, Lee YZ, et al.: Temporal relationship between apparent diffusion coefficient and absolute measurements of cerebral blood flow in acute stroke patients. Stroke 2003, 34:64-70.
2. Baird AE, Warach S: Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998, 18:583-609.
3. Baird AE, Benfield A, Schlaug G, et al.: Enlargement of human cerebral Ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997, 41:581-589.
4. Gonzalez RG, Schaefer PW, Buonanno FS, et al.: Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 1999, 210:155-162.
5. Albers GW. Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. Stroke 1999, 30:2230-2237.
6. Schwamm LH, Koroshetz WJ, Sorensen AG, et al.: Time course of lesion development in patients with acute stroke. Serial diffusion and homodynamic-weighted magnetic resonance imaging. Stroke 1998, 29:2269-2276.
7. Arenillas JF, Rovira A, Molina CA, et al.: Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke. Stroke 2002, 33:2197-2205.
8. Mullins ME, Schaefer PW, Sorensen AG, et al.: CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology 2002, 224:353-360.
9. Gass A, Ay H, Szabo K, et al.: Diffusion-weighted MRI for the "small stuff": the details of acute cerebral ischemia. Lancet Neurol 2004, 3:39-45.
10. Fiehler J, von Bezold M, Kucinski T, et al.: Cerebral blood flow predicts lesion growth in acute stroke patients. Stroke 2002, 33:2421-2425.
11. Schaefer PW, Hunter GJ, He J, et al.: Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging. Am J Neuroradiol 2002, 23:1785-1794.
12. Rordorf G, Koroshetz WJ, Copen WA, et al.: Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted mri. Stroke 1998, 29:939-943.
13. Fiehler J, Knudsen K, Kucinski T, et al.: Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke 2004, 35:514-519.
14. Kidwell CS, Saver JL, Mattiello J, et al.: Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000, 47:462-469.
15. Neumann-Haefelin T, Wittsack HJ, Fink GR, et al.: Diffusion-and perfusion-weighted MRI: influence of severe carotid artery stenosis on the DWI/PWI mismatch in acute stroke. Stroke 2000, 31:1311-1317.
16. Li F, Silva MD, Sotak C, et al.: Temporal evolution of ischemic injury evaluated with diffusion and perfusion and T2-weighted MRI. Neurology 2000, 54:689-696.
17. Kidwell CS, Saver JL, Mattiello J, et al.: Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000, 47:462-469.
18. Kidwell CS, Saver JL, Starkman S, et al.: Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol 2002, 52:698-703.
19. Ay H, Buonanno FS, Rordorf G, et al.: Normal diffusion-weighted MRI during stroke-like deficits. Neurology 1999, 52:1784-1792.
20. Parsons MW, Yang Q, Barber A, et al.: Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke 2001, 32:1581-1587.
21. Sorensen AG, Copen WA, Ostergaard L, et al.: Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 1999, 210:519-527.
22. Schaefer PW, Ozsunar Y, He J, et al.: Assessing tissue viability with MR diffusion and perfusion imaging. Am J Neuroradiol 2003, 24:436-443.
23. Kidwell CS, Alger JR, Saver JL: Evolving paradigms in neuroimaging of the ischemic penumbra. Stroke 2004, 35:2662-2665.
24. Chalela JA, Kang DW, Luby M, et al.: Early MRI findings in patients receiving tissue plasminogen activator predict outcome: insights into the pathophysiology of acute stroke in the thrombolysis era. Ann Neurol 2004, 55:105-112.
25. Latchaw RE, Yonas H, Hunter GJ, et al.: Guidelines and recommendations for perfusion imaging in cerebral ischemia. A scientific statement for healthcare professionals by the writing group on perfusion imaging, from the council on cardiovascular radiology of the American Heart Association. Stroke 2003, 34:1084-1104.
26. Uno M, Harada M, Yoneda K, et al.: Can diffusion- and perfusion-weighted magnetic resonance imaging evaluate the efficacy of acute thrombolysis in patients with internal carotid artery or middle cerebral artery occlusion? Neurosurgery 2002, 50:28-34.
27. Sorenson AC, Buonanno FS, Gonzalez RG, et al.: Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996, 199:391-401.
28. Jansen O, Schellinger P, Fiebach J, et al.: Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet 1999, 353:2036-2037.
29. Sunshine JL, Tarr RW, Lanzieri CF, et al.: Hyperacute stroke: ultrafast MR imaging to triage patients prior to therapy. Radiology 1999, 212:325-332.
30. Nighoghossian N, Hermier M, Adeleine P, et al.: Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke 2003, 34:458-463.
31. Neumann-Haefelin T, Wittsack HJ, Wenserski F, et al.: Diffusion- and perfusion-weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke 1999, 30:1591-1597.
32. Barber PA, Darby DG, Desmond PM, et al.: Prediction of stroke outcome with echo planar perfusion- and diffusion-weighted MRI. Neurology 1998, 51:418-426.
33. Parsons MW, Barber PA, Chalk J, et al.: Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002, 51:28-37.
34. Röther J, Schellinger PD, Gass A, et al.: Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke 2002, 33:2438-2445.
35. Butcher K, Parsons M, Baird T, et al.: Perfusion thresholds in acute stroke thrombolysis. Stroke 2003, 34:2159-2164.
36. Adam HP Jr, Brott TG, Furlan AJ, et al.: Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke 1996, 27:1711-1718.
37. Hermier M, Nighoghossian N: Contribution of susceptibility-weighted imaging to acute stroke assessment. Stroke 2004, 35:1989-1994.
38. Wiesman M, Mayer TE, Yousry I, et al.: Detection of hyperacute subarachnoid hemorrhage of the brain by using magnetic resonance imaging. J Neurosurg 2002, 96:684-689.
39. Fiebach JB, Schelinger PD, Geletneky K, et al.: MRI in acute subarachnoid hemorrhage; findings with a standardized protocol [abstract]. Neuroradiology 2004, 46:44-48.
40. Kidwell CS, Saver JL, Villablanca P, et al.: Magnetic resonance imaging detection of microbleeds before thrombolysis, an emergent application. Stroke 2002, 33:95-98.
41. Nederkoorn PJ, van der Graaf Y, Hunink MG: Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systematic review. Stroke 2003, 34:1324-1332.
42. Nederkoorn PJ, Elgersma OE, van der Graaf Y, et al.: Carotid artery stenosis: accuracy of contrast-enhanced MR angiography for diagnosis. Radiology 2003, 228:677-682.
43. Barber PA, Davis SM, Darby DG, et al.: Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra. Neurology 1999, 52:1125-1132.
44. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587.
45. Marks MP, Tong DC, Beaulieu C, et al.: Evaluation of early reperfusion and IV tPA therapy using diffusion- and perfusion-weighted MRI. Neurology 1999, 52:1792-1798.
46. Schellinger PD, Jansen O, Fiebach JB, et al.: Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke 2000, 31:1318-1328.
47. Hacke W, Albers G, Al-Rawi Y, et al.: The desmoteplase in acute ischemic stroke trial (DIAS), a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005, 36:66-73.
48. Hjort N, Butcher K, Davis SM, et al.: Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 2005, 36:388-397.